Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/2/2020
SIETES contiene 92913 citas

 1 a 20 de 99 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
2.Tiene citas relacionadas Cita con resumen
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith Jr SC, Svetkey LP, Taler SJ, Townsend RR, Wright Jr JT, Narva AS, Ortiz E. 2014 evidence based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. [Ref.ID 97094]
3.Tiene citas relacionadas
Bauchner H, Fontanarosa PB, Golub RM. Updated guidelines for management of high blood pressure: recommendation, review, and responsibility. JAMA 2014;311:477-8. [Ref.ID 97092]
4.Tiene citas relacionadas
Peterson ED, Gaziano JM, Greenland P. Recommendations for treating hypertension: what are the right goals and purposes?. JAMA 2014;311:474-6. [Ref.ID 97091]
6.Tiene citas relacionadas
Giovannucci E. Cholecalciferol treatment in older patients with isolated systolic hypertension. JAMA Intern Med 2013;173:1680-1. [Ref.ID 96381]
7.Tiene citas relacionadas Cita con resumen
Witham MD, Price RJG, Struthers AD, Donnan PT, Messow C-M, Ford I, McMurdo MET. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013;173:1672-9. [Ref.ID 96380]
8. Cita con resumen
Kostis JB, Cabrera J, Cheng JQ, Cosgrove NM, Deng Y, Pressel SL, Davis BR. Association between chlorthalidone treatment of systolic hypertension and long-term survival. JAMA 2011;306:2588-93. [Ref.ID 91979]
10. Cita con resumen
Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins. Results fromo the UCSD Statin Study, a randomized trial. Arch Intern Med 2008;168:721-7. [Ref.ID 82603]
11.Tiene citas relacionadas Cita con resumen
Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008;371:923-31. [Ref.ID 82403]
12.Tiene citas relacionadas Cita con resumen
Mendis S, Mohan V. Non-laboratory-based prediction of cardiovascular risk. Lancet 2008;371:878-9. [Ref.ID 82393]
13.Enlace a cita original Cita con resumen
Chobanian AV. Isolated systolic hypertension in the elderly. N Engl J Med 2007;357:789-96. [Ref.ID 80840]
14. Cita con resumen
Kannel WB, Vasan RS. Aggressive lowering of blood pressure. Lancet 2006;368:627-8. [Ref.ID 77820]
15.Tiene citas relacionadas Cita con resumen
Cruickshank JM. ß blockers for the treatment of primary hypertension. Lancet 2006;367:209. [Ref.ID 75994]
16. Cita con resumen
Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice?. Lancet 2004;364:1684-9. [Ref.ID 71833]
Chaudhry SL, Krumholz HM, Foody JM. Systolic hypertension in older persons. JAMA 2004;292:1074-80. [Ref.ID 71366]
18.Tiene citas relacionadas Cita con resumen
Julius S, Weber MA. VALUE: analysis of results. Authors' reply. Lancet 2004;364:935. [Ref.ID 71321]
19.Tiene citas relacionadas Cita con resumen
Fretheim A. VALUE: analysis of results. Lancet 2004;364:934-5. [Ref.ID 71320]
20.Tiene citas relacionadas Cita con resumen
Kario K, Pickering T. VALUE: analysis of results. Lancet 2004;364:934. [Ref.ID 71319]
Seleccionar todas
 1 a 20 de 99 siguiente >>